Status:
RECRUITING
ESPB vs Intrathecal Morphine for Assessements of Quality of Recovery After Cesarean Section
Lead Sponsor:
AUSL Romagna Rimini
Conditions:
Cesarean Section
Post Operative Pain
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
Cesarean section is a surgical procedure that involves significant pain, which is managed through a multimodal pharmacological approach.The primary objective of the study is to evaluate the quality of...
Detailed Description
Cesarean section is one of the most common surgical procedures worldwide and is associated with significant postoperative pain. Effective pain control is crucial to enhance maternal recovery, improve ...
Eligibility Criteria
Inclusion
- Adult women aged 18-45 years
- ASA physical status II-III
- Full-term singleton pregnancy scheduled for elective cesarean section under spinal anesthesia
Exclusion
- ASA ≥ IV
- Coagulation disorders
- Emergency surgery
- Preoperative infection (including infection at the ESPB puncture site)
- Any contraindication to neuraxial analgesia
- History of chronic pain
- Use of opioids
- Allergy to local anesthetics
- Hypersensitivity to any drug used in the study
- Inability to understand or use verbal pain assessment scales
- Refusal to participate in the study
Key Trial Info
Start Date :
June 18 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT07202416
Start Date
June 18 2025
End Date
June 1 2026
Last Update
October 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AUSL Romagna - Ospedale M.Bufalini
Cesena, Forlì, Italy, 47521